Sermorelin

• Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
  Unknown Phase COMPLETED Stefania La Grutta, MD
• Inter-Assay Growth Hormone and IGF-I Variability
  Unknown Phase WITHDRAWN Cedars-Sinai Medical Center
• Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study
  Unknown Phase COMPLETED University of Roma La Sapienza
• Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
  Unknown Phase COMPLETED University of Erlangen-Nürnberg Medical School
• Endocrine Studies in Health and Disease
  Unknown Phase TERMINATED Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Showing 5 of 24 trials.

• Impact of growth hormone-releasing hormone antagonist on decidual stromal cell growth and apoptosis in vitro†.
  Biol Reprod unknown
• Growth hormone - releasing hormone antagonists induce autophagy in cancer cells.
  Growth Horm IGF Res unknown
• In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.
  Biomed Chromatogr unknown
• Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis.
  Electrophoresis unknown
• Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
  Peptides unknown

Showing 5 of 14 papers by citation count.

FDA Data

Frequently Asked Questions